BlackRock Japan’s Utah Medical Products UTMD Stock Holding History

BlackRock Japan’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-8	Closed	–	–	1315
2014 Q2	$0	Buy	+8	New	+$411	﹤0.01%	1404

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

MDCM

Morgan Dempsey Capital Management Menomonee Falls, Wisconsin $220M AUM 18.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Japan's UTMD Position: Q3 2014 in Review

BlackRock Japan sold out of Utah Medical Products (UTMD) in Q3 2014, closing a stake of 8 shares.

BlackRock Japan first reported a position in UTMD in Q2 2014 and held it in 1 quarter. The position peaked at $0 in Q2 2014. 62 funds tracked by Wall St. Rank hold UTMD as of Q3 2014.

BlackRock Japan reported no remaining Utah Medical Products position as of Q3 2014 after selling out during the quarter.
BlackRock Japan sold 8 Utah Medical Products shares in Q3 2014.
BlackRock Japan first reported a position in Utah Medical Products in Q2 2014 and held it in 1 quarter.
BlackRock Japan's Utah Medical Products position peaked at $0 in Q2 2014.
62 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2014.

Based on BlackRock Japan's 13F filing for Q3 2014, filed 29 Oct 2014.